Dimitrios P. Kontoyiannis, MD, ScD, PhD (Hon), FACP, FIDSA, FECMM, FAAM, FAAAS
Dimitrios P. Kontoyiannis, MD, ScD, PhD (Hon), FACP, FIDSA, FECMM, FAAM, FAAAS
University of Texas MD Anderson Cancer Center
Dirección de correo verificada de - Página principal
Citado por
Citado por
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America
TJ Walsh, EJ Anaissie, DW Denning, R Herbrecht, DP Kontoyiannis, ...
Clinical infectious diseases 46 (3), 327-360, 2008
Epidemiology and outcome of zygomycosis: a review of 929 reported cases
MM Roden, TE Zaoutis, WL Buchanan, TA Knudsen, TA Sarkisova, ...
Clinical infectious diseases 41 (5), 634-653, 2005
Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America
TF Patterson, GR Thompson III, DW Denning, JA Fishman, S Hadley, ...
Clinical infectious diseases 63 (4), e1-e60, 2016
Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group …
JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ...
Clinical Infectious Diseases 71 (6), 1367-1376, 2020
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection …
DP Kontoyiannis, KA Marr, BJ Park, BD Alexander, EJ Anaissie, TJ Walsh, ...
Clinical Infectious Diseases 50 (8), 1091-1100, 2010
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)
PG Pappas, BD Alexander, DR Andes, S Hadley, CA Kauffman, A Freifeld, ...
Clinical Infectious Diseases 50 (8), 1101-1111, 2010
Epidemiology and clinical manifestations of mucormycosis
G Petrikkos, A Skiada, O Lortholary, E Roilides, TJ Walsh, ...
Clinical Infectious Diseases 54 (suppl_1), S23-S34, 2012
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled …
JA Maertens, II Raad, KA Marr, TF Patterson, DP Kontoyiannis, ...
The Lancet 387 (10020), 760-769, 2016
Delaying amphotericin B–based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis
G Chamilos, RE Lewis, DP Kontoyiannis
Clinical Infectious Diseases 47 (4), 503-509, 2008
Pathogenesis of mucormycosis
AS Ibrahim, B Spellberg, TJ Walsh, DP Kontoyiannis
Clinical infectious diseases 54 (suppl_1), S16-S22, 2012
Zygomycosis in a Tertiary-Care Cancer Center in the Era of Aspergillus-Active Antifungal Therapy: A Case-Control Observational Study of 27 Recent Cases
DP Kontoyiannis, MS Lionakis, RE Lewis, G Chamilos, M Healy, ...
The Journal of infectious diseases 191 (8), 1350-1360, 2005
Glucocorticoids and invasive fungal infections
MS Lionakis, DP Kontoyiannis
The Lancet 362 (9398), 1828-1838, 2003
Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases
JAH van Burik, RS Hare, HF Solomon, ML Corrado, DP Kontoyiannis
Clinical Infectious Diseases 42 (7), e61-e65, 2006
Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003)
G Chamilos, M Luna, RE Lewis, GP Bodey, R Chemaly, JJ Tarrand, ...
haematologica 91 (7), 986-989, 2006
Zygomycosis in the 1990s in a tertiary-care cancer center
DP Kontoyiannis, VC Wessel, GP Bodey, KVI Rolston
Clinical Infectious Diseases 30 (6), 851-856, 2000
Recent advances in the management of mucormycosis: from bench to bedside
EJC Goldstein, B Spellberg, TJ Walsh, DP Kontoyiannis, J Edwards Jr, ...
Clinical Infectious Diseases 48 (12), 1743-1751, 2009
Antifungal drug resistance of pathogenic fungi
DP Kontoyiannis, RE Lewis
The Lancet 359 (9312), 1135-1144, 2002
Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program
J Morgan, KA Wannemuehler, KA Marr, S Hadley, DP Kontoyiannis, ...
Medical mycology 43 (Supplement_1), S49-S58, 2005
Combination antifungal therapy for invasive aspergillosis: a randomized trial
KA Marr, HT Schlamm, R Herbrecht, ST Rottinghaus, EJ Bow, OA Cornely, ...
Annals of internal medicine 162 (2), 81-89, 2015
When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis
TM John, CN Jacob, DP Kontoyiannis
Journal of fungi 7 (4), 298, 2021
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20